Clinical Trials Update: Oct. 27, 2006
Hot Flash Generalized Anxiety Disorder (GAD) Ulcerative Colitis
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This study will evaluate a non-hormonal investigational medication to see if it can help control hot flashes. You may be eligible to participate if you are at least 40 years old, have hot flashes and night sweats, had your last period at least six months ago, and are prepared not to use hormone therapy or antidepressants during the 12-week study.
The research site is in Stockbridge, Ga.
Generalized Anxiety Disorder (GAD)
This trial will include an 8-week treatment phase followed by a 2 week follow-up phase testing quetiapine, paroxetine or placebo as monotherapy for generalized anxiety disorder (GAD). Volunteers 18-65 with a clinically documented diagnosis of GAD who do not have any other psychiatric diagnosis, have not been treated with paroxetine or quetiapine the last six months, and are not pregnant or breast feeding may be eligible.
The research site is in Kelowna, BC, Canada.
This clinical research study seeks volunteers 18-75 with symptoms of moderate active ulcerative colitis. Study medications and medical monitoring will be available for qualified participants at no cost, and compensation will be available for time and travel.
The research site is in Tucson, Ariz.
Copyright 2006 Thomson CenterWatch. All rights reserved.